Put companies on watchlist
HBM Healthcare Investments AG
ISIN: CH0012627250
WKN: 984345
About
Company Snapshot
New: Enable Investor Alerts
Be informed about new publications
New: AI Factsheet

Corporate News meets AI! 
Content analysis and summary

EN GIF 300X250

HBM Healthcare Investments AG · ISIN: CH0012627250 · EQS - adhoc news (191 News)
Country: Switzerland · Primary market: Switzerland · EQS NID: 1180719
01 April 2021 07:26PM

Key Figures 31.03.2021


EQS Group-Ad-hoc: HBM Healthcare Investments AG / Key word(s): Monthly Figures
Key Figures 31.03.2021

01-Apr-2021 / 19:26 CET/CEST
Release of an ad hoc announcement pursuant to Art. 53 KR
The issuer is solely responsible for the content of this announcement.


 

in CHF

Performance in %

 

31.03.2021

MTD

FYTD

CYTD

NAV

CHF 309.25

0.7%

52.2%

5.5%

Share Price

CHF 332.50

2.3%

79.1%

9.0%

Total Net Assets (in million)

2'151

 

 

 

MTD      Month to Date
FYTD     Financial Year to Date (since 1.4.2020)
CYTD    Calendar Year to Date (since 1.1.2021)



End of ad hoc announcement
Language: English
Company: HBM Healthcare Investments AG
Bundesplatz 1
6300 Zug
Switzerland
Phone: +41438887171
Fax: +41438887172
E-mail: info@hbmhealthcare.com
Internet: https://www.hbmhealthcare.com
ISIN: CH0012627250
Valor: 1262725
Listed: SIX Swiss Exchange
EQS News ID: 1180719

 
End of Announcement EQS Group News Service

1180719  01-Apr-2021 CET/CEST

fncls.ssp?fn=show_t_gif&application_id=1180719&application_name=news&site_id=boersengefluester_html
Visual performance / price development - HBM Healthcare Investments AG
Smart analysis and research tools can be found here.

This publication was provided by our content partner EQS3.

EQS Newswire
via EQS - Newsfeed
EQS Group AG ©2024
(DGAP)
Contact:
Karlstraße 47 D-80333 München
+49 (0) 89 444 430-000

 

SMART * AD
EN GIF 970X250

P R O D U C T   S U G G E S T I O N S

The information presented here has been provided by our content partner EQS-Group. The originator of the news is the respective issuer, the company relating to the news, a publication service provider (press or information agency) which uses the distribution service of EQS to transmit company news to shareholders, investors, investors or interested parties. The original publications and other company-relevant information can be found at eqs-news.com.


The information you can access does not constitute investment advice. The presentation of our cooperation partners, where the implementation of investment decisions would be possible depending on the individual risk profile, is solely at the discretion of the person using the service. We only present companies of which we are convinced that the range of services and customer service will satisfy discerning investors.

If you are considering leverage products, familiarise yourself with the typical characteristics of the financial instruments beforehand. Take the time to determine the risk content of the planned investment before making an investment decision. Bear in mind that a total loss cannot be ruled out with leverage products.

For newcomers to the subject, we offer various options in both the training and the tools section, through which you can train theoretical knowledge and practical experience and thus improve your skills. The offer ranges from participation in webinars to personal mentoring. The range is continuously being expanded.


1 Lab features are usually functionalities that emerge from the think tank of the investor community. In the early stages, these are experimental functionalities whose development process is largely determined by use and the resulting feedback from the community. When integrating external services or functionalities, the functionality can only be guaranteed to the extent that the individual process elements, such as interfaces, interact with each other.